California's EWC program: Cuts alarm breast cancer survivors and advocates

NewsGuard 100/100 Score

Breast cancer survivors and advocates from all seven California Affiliates of Susan G. Komen for the Cure® signaled their alarm today at the recently announced cuts to California's Every Woman Counts program, which would effectively shut the doors to breast cancer screening services for 1.2 million low-income and uninsured women for the first six months of 2010.

Citing budgetary concerns, the state also announced that once they begin screening new patients this summer, only women age 50 and above will be eligible - significantly reducing the number of women in the state that will have access to affordable breast cancer screenings.

"We fully understand the tough economic situation our elected leaders face and the difficult choices they must make. Yet balancing the budget on the backs of our state's neediest women is a mistake. We should not deny women who have very few options and limited resources access to screening and treatment services that may save their life," said Donna R. Sanderson, Ed. D, Founder, California Collaborative of Susan G. Komen for the Cure.

Every Women Counts (EWC) is a joint program by the state Department of Public Health and the Center for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program. Komen Affiliates noted that while 1.2 million women are eligible for EWC, the program only screens about 270,000 women a year, approximately 77,000 of whom are under age 50.

The news about changes to EWC come on the heels of new mammography screening recommendations recently unveiled by the U.S. Preventive Services Task Force (USPSTF), which generated significant controversy and confusion for women. Some have interpreted the guidelines as a recommendation against mammography for women age 40 to 49. In fact, the task force actually intended to encourage women to talk with their providers and assess their personal risk factors in deciding whether to have a mammogram. However it was intended, the potential for impediments to screening based on the guidelines exist.

"Women ages 40 to 49 must have access to mammography if they need it," said Jennifer Luray, president of the Susan G. Komen for the Cure Advocacy Alliance. "As states across the country struggle to balance their budgets, we will be watching to ensure the USPSTF recommendations are not used as a justification for slashing these critical services to women in need."

Early detection of breast cancer is a key to surviving the disease. When breast cancer is detected early, the 5-year relative survival rate is 98 percent, but declines to 84 percent for regional disease and 23 percent when cancer has metastasized or spread to other parts of the body. Unfortunately, women with low incomes who are uninsured or underinsured -- like those eligible for Every Women Counts -- are more likely to skip potentially life-saving cancer screenings, which leads to later diagnoses, larger tumors and lower survival rates.

In California alone, 21,700 women will have been diagnosed with breast cancer this year and more than 4,000 will have lost their battle with the disease.

"We know the need will continue regardless of the ability of the state to meet it. Komen Affiliates will continue to do our part to meet the needs of underserved women; yet, these resources are extremely limited and not available in all areas. We cannot do this alone," said Sanderson. "Komen for the Cure and its Affiliates have long been concerned that one-third of women in the U.S. today -- some 23 million -- are already not receiving regular recommended screenings due to lack of access, education or awareness. Unfortunately, the decision to restrict access to the Every Woman Counts program makes the problem even worse."

SOURCE Susan G. Komen for the Cure

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough imaging method enhances precision in prostate cancer treatment